To report the 3-year results of a prospective, single arm, multicenter, international clinical study with the second generation of the temporary implantable nitinol device (iTIND; Medi-Tate Ltd®, Israel) on men suffering lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).
3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction
Amparore, Daniele
;Fiori, Cristian;De Cillis, Sabrina;Porpiglia, Francesco
2021-01-01
Abstract
To report the 3-year results of a prospective, single arm, multicenter, international clinical study with the second generation of the temporary implantable nitinol device (iTIND; Medi-Tate Ltd®, Israel) on men suffering lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s41391-020-00281-5.pdf
Accesso aperto
Dimensione
798.75 kB
Formato
Adobe PDF
|
798.75 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
